Franklin Libenson, Md Mph Email & Phone Number

San Diego, California, United States

Operating from the San Diego office, in collaboration with our Rotterdam site, I work alongside the CEO and executive team to craft and execute a comprehensive growth strategy. This involves identifying and pursuing new business opportunities, including forging partnerships, enhancing internal sales, and exploring market expansion. I lead a dedicated team, driving them towards achieving our ambitious growth objectives, and ensure the implementation of effective pricing and go-to-market strategies.My responsibilities extend to monitoring market trends and competitor activities, providing me with insights to adapt and refine our strategies dynamically. I manage the budget for growth initiatives, ensuring optimal allocation of resources to support our objectives. Technology plays a crucial role in our growth efforts, and part of my duty is to identify and implement tools that aid in our expansion. Regular reporting to the CEO and the executive team on our growth performance is a critical part of my role, ensuring transparency and alignment with our overall corporate strategy.As a key member of the executive team, I contribute to the direction and strategy of SkylineDx. My role as the chief vocal advocate for the organization involves ensuring that our marketing and sales teams are equipped with current and relevant information. I oversee the operations of these teams, actively leading sales activities, and engaging in sales demonstrations and closures. My approach is metrics-driven and analytical, allowing me to be a strategic thinker who formulates policies and planning recommendations to the CEO, aiming to continuously drive the company towards greater heights of success.

San Diego, California, United States

-Managed full P&L responsibility as a global marketing and sales leader across multiple regions, demonstrating strong financial and operational acumen.-Established a robust network of over 400 top global oncology Key Opinion Leaders (KOLs), showcasing exceptional relationship-building and networking skills.-Drove sales growth in diverse markets, including APAC, Europe, Canada, and LATAM, indicating a broad understanding of different regional market dynamics.-Aligned organizational functions with strategic commercial objectives by restructuring the US sales team into regional Business Units, integrating roles like Clinical Application Specialists, Medical Scientific Liaisons, and Customer Care representatives.-Addressed challenges in the European region by installing new commercial leadership, fostering a collaborative culture, and turning around the struggling market.-Led the successful market entry into Ontario, Canada, implementing a reimbursement path for MammaPrint, which increased market share and generated approximately $3M/year in revenue, highlighting effective market penetration and growth strategies.❇️ Grew Canadian market share from 0% to 40% in 18 months❇️ Achieved significant sales growth across APAC (including China), Europe, and LATAM regions❇️ Increased annual revenues in APAC by 100% ❇️ Successfully launched the Endocrine Management clinical utility for the MammaPrint test in a record three months

San Diego, California, United States

My primary responsibility as Senior Vice President of International Sales was to accelerate the adoption of the global MammaPrint breast cancer risk of recurrence assay. I focused primarily on entering the APAC market and deploying the MammaPrint NGS solution to achieve this goal.I achieved significant market share growth in Brazil and Mexico through strategic initiatives such as cost-effectiveness studies, national reimbursement, and entry into national formularies. As my role expanded, I took on additional responsibilities, including turning around the struggling European region, entering the Canadian market, and leading sales efforts across international markets.To further expand the adoption of our product globally, I spearheaded the development and launch of the NGS decentralized solution for MammaPrint, which obtained European CE Mark in 2018. I also provided comprehensive commercial support to ensure that the launch was successful.My efforts resulted in significant achievements, including turning around the struggling European region and achieving 20% YoY sales growth. I also led market expansion in key APAC markets and obtained a $500k investment to initiate sales in Mainland China.❇️ Represented ~25% of the company’s revenue, with full P&L responsibility for global market development and sales across APAC, EU, LATAM, and Puerto Rico❇️Developed and implemented market access initiatives in APAC’s most important markets (China, Japan, Korea, Australia, Singapore, Malaysia, Indonesia, Thailand & Philippines)❇️ Successfully trained international sales teams and physicians on sales and clinical utility of products❇️Coordinated commercial activities with partners and oncology stakeholders ❇️ Cultivated strong relationships with key oncology groups, physicians, and stakeholders, resulting in substantial market share growth, successful product launches, and effective market access initiatives

Irvine, Ca

Encompassing a wide range of critical functions, I established a bridge between clinical needs, technology, and market demand, providing leadership and direction for the global marketing of our groundbreaking genomic testing solutions. Developing comprehensive, rational, and cohesive marketing plans that aligned with the company’s overall business objectives, I guided product planning and portfolio management strategies, including R&D, global marketing, and promotional activities. I streamlined projects from 69 to 12, redirecting resources to the top 5 priorities, creating efficiencies, generating better strategy and focus, and positively impacting revenue and the bottom line. Leading the marketing initiatives for MINDACT, I spearheaded efforts that resulted in significant revenue increases of 23% in FY 2016 and 36% in FY 2017. These efforts aimed to increase awareness and adoption of MINDACT’s genomic testing solution for breast cancer patients.As a result of these efforts, MINDACT received an exclusive guideline recommendation from the American Society of Clinical Oncology (ASCO) for the use of MammaPrint in lymph-node-positive patients. This recognition further established MINDACT as a breast cancer genomic testing leader and validated our marketing approach. ASCO® now recommends MammaPrint® for clinical high-risk, hormone receptor-positive, HER2-negative breast cancer to guide decisions on withholding chemotherapy.❇️ Led full scope of marketing and training functions❇️ Improved product messaging and launched the NGS MammaPrint solution❇️ Oversaw market research, product requirements, and commercial strategy for decentralized laboratory adoption.❇️ Coordinated 12+ global oncology symposiums ❇️ Managed global speaker bureau of 60 physicians, providing speaker training, highlighting the product messaging and value proposition❇️ Oversaw extensive planning and execution for conferences, including ASCO, SABCS, ESMO, and ECO

Irvine, Ca

Building on my success in overseeing sales in Latin America, I advanced my position to focus on gaining global distributor contracts. Working to build a broader international reach, I engaged with countries across Asia, Europe, Latin America, and China, ultimately growing to reach over 35 global distributors.In overseeing worldwide distributor relationships, I leveraged my expertise to negotiate and execute new contracts with all 35 EMEA, APAC, and LATAM distributors. Through my efforts, I successfully expanded the reach of our products and services, providing millions worldwide access to life-saving medical technology.❇️Delivered a 40% profitable sales growth over two years❇️Established critically valuable relationships with medical and surgicaloncologists and molecular pathologists❇️Coordinated medical training/presentations to key opinion leaders in sales territories

Irvine, Ca

Focused on overhauling the LATAM region, I promoted the Agendia product portfolio at more than 30 international oncology conferences and symposiums, engaging with key opinion leaders and in physician and physician clinical discussions, which led to strategic initiatives that garnered broad support and product endorsement. Penetrating the top 9 markets in Latin America, my efforts led to increased growth and revenue, earning me a reputation for success. LATAM became the most profitable region in 2013.❇️ Increased sales by 400% over 24 months, reaching breakeven in 5 months.❇️Drove sales increases via the introduction of a positive reimbursement policy for oncology products/services in private/public top markets

San Diego, California, United States

Liamar Healthcare, a specialized consultancy firm, excels in facilitating the international expansion of companies within the molecular diagnostics sector, particularly in oncology. Our expertise extends to advancing NGS (Next-Generation Sequencing) technologies and capital sales, positioning us uniquely in the global medical industry. At the helm is a seasoned biotech and molecular diagnostics executive with over two decades of experience.Our areas of expertise encompass not only strategic planning and crisis management but also global business development with a focus on MolecularDx technologies. We are committed to fostering innovation and building robust partnerships worldwide, leveraging our deep knowledge and experience in international markets to drive successful expansion for our clients in the rapidly evolving field of molecular diagnostics.❇️ Sales Structure Enhancement❇️ Research Oversight❇️ Strategic Planning❇️ Crisis Management❇️ Market Entry Strategies❇️ Operational Optimization❇️ Strategic Partnerships❇️ Global Expertise APAC, EU, Canada & LATAM

Mexico

Recruited by the Governor of the State of Mexico to serve as the Mexican Secretariat of Health, I oversaw all health-related activities that impacted its 15 million residents.Instrumental in establishing the State Center for Disease Control, which became a platform for evidence-based public policy and epidemiologic analysis, I significantly impacted disease prevention efforts and improved health outcomes across the State of Mexico. My leadership skills, problem-solving abilities, and deep understanding of public health policy were amplified during the H1N1 flu epidemic State of Emergency. Rapidly forming a strategic committee, I led the implementation of various health programs and initiatives, effectively treating patients and minimizing the epidemic’s negative impact on the people and the State of Mexico’s economic position. ❇️ Formulated a comprehensive strategic plan to address the H1N1 swine flu epidemic❇️ Oversaw the development and construction of 23 hospitals and 100s of medical clinics ❇️ Hand selected by the Governor of the State of Mexico❇️ Led Statewide project to combat H1N1 swine flue virus, overseeing 15 direct reports and indirectly managing 68,000 employees

Mexico

As a subsidiary of McKesson, a leading provider of medicines, pharmaceutical supplies, and health information technology products in the United States and Mexico, I was tasked with developing and implementing strategies to increase market share in specialty pharmaceutical sales, specifically in oncology, rheumatology, and infectious disease, as well as penetrate the private hospital market. By introducing a new strategy for carrying specialty drugs in hospitals and medical offices and redefining the sales process, we were able to capitalize on new opportunities and drive significant sales growth for our specialty drugs.Strategically complementing our product catalog, I successfully led the acquisition of a prominent vaccine distribution company. This acquisition expanded our offerings and played a critical role in further enhancing our sales efforts. ❇️ Championed strategic and sales efforts, increasing sales from $25M/year to $100M/year within two years❇️ Developed strong relationships with key influencers across the top 5 LATAM oncology pharmaceutical distributors❇️ Spearheaded Oncology Pharma Sales❇️ Reported directly to the CEO

Masters In Public Health (Mph), Healthcare Management

Medical Degree, Medicine

Medical Internship, Medicine, Jackson Memorial Hospital